Xianglin Zhang

1.2k total citations
54 papers, 700 citations indexed

About

Xianglin Zhang is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Xianglin Zhang has authored 54 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pharmacology and 9 papers in Infectious Diseases. Recurrent topics in Xianglin Zhang's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Xianglin Zhang is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Xianglin Zhang collaborates with scholars based in China, United States and Hong Kong. Xianglin Zhang's co-authors include Suodi Zhai, Kehu Yang, Ken Chen, Guanhua Du, Pengmei Li, Xiaoyan Ke, Xiaoxing Wang, Xiaoxue Wang, Tie Zhao and Yaolong Chen and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Epidemiology and International Journal of Cancer.

In The Last Decade

Xianglin Zhang

52 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianglin Zhang China 14 186 170 167 129 67 54 700
Yuhki Sato Japan 15 188 1.0× 153 0.9× 98 0.6× 83 0.6× 56 0.8× 78 762
Jinmiao Lu China 19 114 0.6× 119 0.7× 373 2.2× 115 0.9× 183 2.7× 70 1000
Michel Lavit France 14 95 0.5× 186 1.1× 72 0.4× 133 1.0× 34 0.5× 36 643
Satoshi Kishino Japan 16 232 1.2× 127 0.7× 197 1.2× 176 1.4× 21 0.3× 56 711
Hongyi Tan China 16 104 0.6× 63 0.4× 460 2.8× 155 1.2× 71 1.1× 51 1.2k
Olivier Tribut France 19 298 1.6× 296 1.7× 184 1.1× 416 3.2× 62 0.9× 48 1.4k
Romain Guilhaumou France 15 206 1.1× 537 3.2× 113 0.7× 297 2.3× 22 0.3× 64 1.0k
Samer Mouksassi United States 15 50 0.3× 207 1.2× 184 1.1× 123 1.0× 115 1.7× 37 974
Zui Zou China 23 151 0.8× 60 0.4× 277 1.7× 177 1.4× 79 1.2× 66 1.4k
Stephanie E. Reuter Australia 17 148 0.8× 267 1.6× 337 2.0× 143 1.1× 191 2.9× 58 1.1k

Countries citing papers authored by Xianglin Zhang

Since Specialization
Citations

This map shows the geographic impact of Xianglin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglin Zhang more than expected).

Fields of papers citing papers by Xianglin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglin Zhang. The network helps show where Xianglin Zhang may publish in the future.

Co-authorship network of co-authors of Xianglin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglin Zhang. A scholar is included among the top collaborators of Xianglin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglin Zhang. Xianglin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Bo, Xiaoxue Wang, Wenqian Chen, et al.. (2024). A fully validated LC‑MS/MS method for quantifying bevacizumab in plasma samples from patients with NSCLC and its implications in therapeutic drug monitoring. Oncology Letters. 27(5). 223–223. 3 indexed citations
3.
Zhang, Wei, Na Yu, Qiongye Dong, et al.. (2024). SpaGRA: Graph augmentation facilitates domain identification for spatially resolved transcriptomics. Journal of genetics and genomics. 52(1). 93–104. 1 indexed citations
4.
Li, Bo, Wenqian Chen, Xiaoxue Wang, et al.. (2023). A fully validated method for simultaneous determination of icotinib, osimertinib, gefitinib and O-desmethyl gefitinib in human plasma using UPLC-MS/MS for therapeutic drug monitoring. Journal of Pharmaceutical and Biomedical Analysis. 236. 115697–115697. 4 indexed citations
5.
Chen, Chaoyang, et al.. (2023). Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis. Frontiers in Pharmacology. 14. 1132367–1132367. 10 indexed citations
6.
Chen, Wenqian, Ruihao Zhang, Ziying Chen, et al.. (2022). The population pharmacokinetics and dose optimization of polymyxin B in critically ill patients with or without extracorporeal membrane oxygenation. Journal of Clinical Pharmacy and Therapeutics. 47(10). 1608–1618. 8 indexed citations
7.
Chen, Wenqian, Xiaoxue Wang, Bo Li, et al.. (2022). Effects of Voriconazole Exposure on the Pharmacokinetics of Tacrolimus in Lung Transplantation Patients, Based on Therapeutic Drug Monitoring Data. The Journal of Clinical Pharmacology. 62(10). 1310–1320. 6 indexed citations
8.
Zhou, Pengxiang, Xiaoling Wang, Xianglin Zhang, et al.. (2021). Recommendations on off‐label use of intravenous azithromycin in children. International Journal of Clinical Practice. 75(7). e14010–e14010. 11 indexed citations
9.
Du, Wenwen, Xiaoxing Wang, Dan Zhang, et al.. (2021). The impact of cytochrome P450 3A5 genotype on early tacrolimus metabolism and clinical outcomes in lung transplant recipients. International Journal of Clinical Pharmacy. 44(2). 418–427. 2 indexed citations
10.
Chen, Wenqian, Min Li, Zhu Zhang, et al.. (2020). Influence of venovenous extracorporeal membrane oxygenation on pharmacokinetics of vancomycin in lung transplant recipients. Journal of Clinical Pharmacy and Therapeutics. 45(5). 1066–1075. 9 indexed citations
11.
Zhang, Lei, Kun Tang, Li Zhao, et al.. (2019). Effect of heat shock protein 70 modulators on the development of morphine analgesic tolerance in rats. Behavioural Pharmacology. 31(2&3). 179–185. 4 indexed citations
12.
Liu, Yanping, Qinglong Liu, Xianglin Zhang, et al.. (2018). Bioactive monoterpene indole alkaloids from Nauclea officinalis. Bioorganic Chemistry. 83. 1–5. 46 indexed citations
13.
Yang, Juan, Yupeng Wang, Qianqian Zhao, et al.. (2017). Association of serum uric acid with increased risk of cancer among hypertensive Chinese. International Journal of Cancer. 141(1). 112–120. 23 indexed citations
14.
Wang, Rui, et al.. (2016). Expert consensus on the therapeutic drug monitoring of vancomycin in China. 32(17). 1636. 1 indexed citations
15.
Zhao, Tie, Jun He, Xiaoxue Wang, et al.. (2014). Rapid detection and characterization of major phenolic compounds in Radix Actinidia chinensis Planch by ultra-performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 98. 311–320. 32 indexed citations
16.
Zhang, Xianglin. (2011). Discussion on the Situation of Drug Post-marketed Reassessment in China. 1 indexed citations
17.
Zhang, Xianglin. (2010). HPLC-MS/MS Determination of Oleanolic Acid in Human Plasma. Zhōnghuá yàoxué zázhì. 1 indexed citations
18.
Zhang, Xianglin. (2009). UPLC-MS/MS determination of nicardipine hydrochloride in human plasma. Yaowu fenxi zazhi. 1 indexed citations
19.
Zhang, Xianglin. (2004). Analysis on the Intercepted Situation of the Entry Plant Pests and the Quarantine & Supervisory Measures in Xinjiang. Xinjiang nongye kexue.
20.
Zhang, Xianglin. (2004). Relationship between inflammation and serum albumin levels in hemodialysis patients. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026